As the end of the year approaches it's always tempting to look back and review whats happened over the past 12 months. For Mike Spear though, he's about to head off into the welcoming arms of retirement.
Market forecasts for bioproducts are upbeat. One even predicts that industrial biotechnology will be a $160 billion global business by 2010. Industrial biotechnology first took off in the early 1980s; what gives today's activity a buzz of excitement is the repeat of something else from that era: high energy prices.
Classic distributed control systems typically remain only in high-availability refining and power applications, but their strategies and capabilities persist in descendants and todays sophisticated networks.
Experts forecast modest economic growth at best. The global economy is slowing, led by a pronounced weakness in the United States resulting from the housing downturn and the credit crunch. And this, of course, will significantly impact the chemical industry.